BioBridge Global, a San Antonio-based biomedical company, has made multiple tactical changes and investments recently as demand for its products and services increased significantly over the last year, with revenue from its businesses eclipsing $170 million. The collective revenue at BioBridge…
News
- BioBridge Global making investments for big-time growth
- China's next economic czar: Harvard-trained Xi adviser
He has told foreign businesspeople he favors free markets and disagrees with plans for state-led development of industries from electric cars to robots to biotech. "There is a sense of urgency among Xi's people, including Liu He, that reforms have lagged behind," said Dali Yang, a University of…
- Big pharma's under increasing pressure, and now everyone's just waiting for a 'detonator' to set off ...
That puts pressure on the biotech and pharmaceutical companies that make the drugs, putting them in a position where they have less leverage when negotiating how the drug will get paid for. To counter that, biotech and pharma will have to do big deals of their own, Goldman Sachs analysts wrote…
- US stocks end mostly lower as midday gains slip away
Arcus Biosciences Founder and CEO Terry Rosen, right, is applauded as he rings a ceremonial bell when his company's IPO begins trading on the floor of the New York Stock Exchange, Thursday, March 15, 2018. Arcus Biosciences Founder and CEO Terry Rosen, right, is applauded as he rings a…
- Worldwide study triples number of known genetic risk factors for stroke
UT Health's schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced more than 33,000 alumni who are advancing their fields throughout the world. With seven campuses in San Antonio and Laredo, UT Health San Antonio has a FY 2018 revenue…